NEUROMUSCULAR BLOCKADE REVERSAL AGENT
Clinical trials for NEUROMUSCULAR BLOCKADE REVERSAL AGENT explained in plain language.
Never miss a new study
Get alerted when new NEUROMUSCULAR BLOCKADE REVERSAL AGENT trials appear
Sign up with your email to follow new studies for NEUROMUSCULAR BLOCKADE REVERSAL AGENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Anesthesia reversal drug may trigger jaw spasms – study investigates risks
Knowledge-focused Recruiting nowThis study looks at whether sugammadex, a drug used to reverse muscle relaxants after surgery, causes jaw clenching. Researchers will compare different doses of sugammadex to a standard reversal combination in adults undergoing elective surgery. The goal is to understand how ofte…
Matched conditions: NEUROMUSCULAR BLOCKADE REVERSAL AGENT
Phase: NA • Sponsor: Wonkwang University Hospital • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Eye-Opening study: which anesthesia reversal drug is safer for your eyes?
Knowledge-focused Recruiting nowThis study compares two drugs—sugammadex and neostigmine—used to reverse muscle relaxation after surgery. Researchers will measure the optic nerve sheath diameter (the nerve behind the eye) using ultrasound at key times during recovery. The goal is to see if one drug causes less …
Matched conditions: NEUROMUSCULAR BLOCKADE REVERSAL AGENT
Phase: PHASE4 • Sponsor: Cukurova University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC